Professor Andy Black has joined Lucid Group as non-executive Chairman of the Board

An experienced board-level executive for the life sciences industry, Professor Andy Black, has joined Lucid Group as non-executive Chairman of the Board.

Winner of six Fast Track awards and co-founder of Kinapse, Professor Black, is a Professor of Practice at King’s College London. He supports both the university and King’s Health Partners with commercial partnerships and teaches entrepreneurship.

Professor Black’s extensive management and pharmaceutical experience will help inform Lucid Group’s development and growth strategy to advance the group towards its goal of bringing together the industry.

Professor Black’s vast management and pharmaceutical experience will aid Lucid Group’s growth and development strategy, moving the company closer to its vision of bringing together industry-leading capabilities to confront some of the most challenging healthcare problems using an outcomes-driven approach.

CEO and co-founder, Lucid Group, Dennis O’Brien, stated: “We are delighted to welcome Andy to the Lucid Group as Chairman. His deep industry knowledge, people focus and experience building a strategic consultancy business, make him invaluable in supporting our global development and growth. He is deeply passionate about making a difference to people’s lives which is directly aligned to the Lucid vision.”

Chairman of the Board, Lucid Group, Andy Black, stated: “I am delighted to be taking on the position of Chairman of the Board at Lucid Group. We share the same values and passion for attracting, developing and retaining the best people to fuel a purpose-driven organisation. I look forward to working closely with our great team as it continues to build the world’s best healthcare solutions business and transform patients’ lives around the world.”